img

Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Guided bone regeneration (GBR) and guided tissue regeneration (GTR) are dental surgical procedures that use barrier membranes to direct the growth of new bone and gingival tissue at sites with insufficient volumes or dimensions of bone or gingiva for proper function, esthetics or prosthetic restoration. Guided bone regeneration typically refers to ridge augmentation or bone regenerative procedures; guided tissue regeneration typically refers to regeneration of periodontal attachment.
The global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane include Geistlich Pharma, Keystone Dental, Yantai Zhenghai Bio-tech, Bio-tech, Genoss, MegaGen Impant, Sunstar, OraPharma and Biomedical Tissues, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Geistlich Pharma
Keystone Dental
Yantai Zhenghai Bio-tech
Bio-tech
Genoss
MegaGen Impant
Sunstar
OraPharma
Biomedical Tissues
Botiss
Dentsply Sirona
Zimmer Biomet
Lynch Biologics
Neoss Limited
Biomatlante
Nobel Biocare Services/Danaher Corporation
Salvin Dental Specialties,Inc
By Type
Absorbable Membrane
Non-resorbable Membrane
By Application
Hospital
Clinic
Dental
Other
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Definition
1.2 Market by Type
1.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Absorbable Membrane
1.2.3 Non-resorbable Membrane
1.3 Market Segment by Application
1.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Dental
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales
2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Estimates and Forecasts 2018-2034
2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region
2.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2018-2024)
2.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2024-2034)
2.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region
2.6.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region (2018-2024)
2.6.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Manufacturers
3.1.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales in 2022
3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Manufacturers
3.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Manufacturers (2018-2024)
3.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue in 2022
3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Price by Manufacturers
3.4 Global Key Players of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Product Offered and Application
3.8 Global Key Manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type
4.1.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Market Share by Type (2018-2034)
4.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type
4.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Historical Revenue by Type (2018-2024)
4.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Forecasted Revenue by Type (2024-2034)
4.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Type (2018-2034)
4.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Type
4.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Type (2018-2024)
4.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application
5.1.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Market Share by Application (2018-2034)
5.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application
5.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Historical Revenue by Application (2018-2024)
5.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Forecasted Revenue by Application (2024-2034)
5.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Application (2018-2034)
5.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Application
5.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Application (2018-2024)
5.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price Forecast by Application (2024-2034)
6 North America
6.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Company
6.1.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024)
6.1.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024)
6.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Type
6.2.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2034)
6.2.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2034)
6.3 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Application
6.3.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2034)
6.3.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2034)
6.4 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Country
6.4.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2018-2034)
6.4.3 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Company
7.1.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024)
7.1.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024)
7.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Type
7.2.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2034)
7.2.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2034)
7.3 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Application
7.3.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2034)
7.3.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2034)
7.4 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Country
7.4.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2018-2034)
7.4.3 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Company
8.1.1 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024)
8.1.2 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024)
8.2 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Type
8.2.1 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2034)
8.2.2 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2034)
8.3 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Application
8.3.1 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2034)
8.3.2 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Company
9.1.1 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024)
9.1.2 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024)
9.2 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Type
9.2.1 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2034)
9.2.2 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2034)
9.3 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Application
9.3.1 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2034)
9.3.2 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2034)
9.4 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Region
9.4.1 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2018-2034)
9.4.3 APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Company
10.1.1 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Type
10.2.1 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Application
10.3.1 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size by Country
10.4.1 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Geistlich Pharma
11.1.1 Geistlich Pharma Company Information
11.1.2 Geistlich Pharma Overview
11.1.3 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.1.5 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.1.6 Geistlich Pharma Recent Developments
11.2 Keystone Dental
11.2.1 Keystone Dental Company Information
11.2.2 Keystone Dental Overview
11.2.3 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.2.5 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.2.6 Keystone Dental Recent Developments
11.3 Yantai Zhenghai Bio-tech
11.3.1 Yantai Zhenghai Bio-tech Company Information
11.3.2 Yantai Zhenghai Bio-tech Overview
11.3.3 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.3.5 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.3.6 Yantai Zhenghai Bio-tech Recent Developments
11.4 Bio-tech
11.4.1 Bio-tech Company Information
11.4.2 Bio-tech Overview
11.4.3 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.4.5 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.4.6 Bio-tech Recent Developments
11.5 Genoss
11.5.1 Genoss Company Information
11.5.2 Genoss Overview
11.5.3 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.5.5 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.5.6 Genoss Recent Developments
11.6 MegaGen Impant
11.6.1 MegaGen Impant Company Information
11.6.2 MegaGen Impant Overview
11.6.3 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.6.5 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.6.6 MegaGen Impant Recent Developments
11.7 Sunstar
11.7.1 Sunstar Company Information
11.7.2 Sunstar Overview
11.7.3 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.7.5 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.7.6 Sunstar Recent Developments
11.8 OraPharma
11.8.1 OraPharma Company Information
11.8.2 OraPharma Overview
11.8.3 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.8.5 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.8.6 OraPharma Recent Developments
11.9 Biomedical Tissues
11.9.1 Biomedical Tissues Company Information
11.9.2 Biomedical Tissues Overview
11.9.3 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.9.5 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.9.6 Biomedical Tissues Recent Developments
11.10 Botiss
11.10.1 Botiss Company Information
11.10.2 Botiss Overview
11.10.3 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.10.5 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
11.10.6 Botiss Recent Developments
11.11 Dentsply Sirona
11.11.1 Dentsply Sirona Company Information
11.11.2 Dentsply Sirona Overview
11.11.3 Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.11.5 Dentsply Sirona Recent Developments
11.12 Zimmer Biomet
11.12.1 Zimmer Biomet Company Information
11.12.2 Zimmer Biomet Overview
11.12.3 Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.12.5 Zimmer Biomet Recent Developments
11.13 Lynch Biologics
11.13.1 Lynch Biologics Company Information
11.13.2 Lynch Biologics Overview
11.13.3 Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.13.5 Lynch Biologics Recent Developments
11.14 Neoss Limited
11.14.1 Neoss Limited Company Information
11.14.2 Neoss Limited Overview
11.14.3 Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.14.5 Neoss Limited Recent Developments
11.15 Biomatlante
11.15.1 Biomatlante Company Information
11.15.2 Biomatlante Overview
11.15.3 Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.15.5 Biomatlante Recent Developments
11.16 Nobel Biocare Services/Danaher Corporation
11.16.1 Nobel Biocare Services/Danaher Corporation Company Information
11.16.2 Nobel Biocare Services/Danaher Corporation Overview
11.16.3 Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.16.5 Nobel Biocare Services/Danaher Corporation Recent Developments
11.17 Salvin Dental Specialties,Inc
11.17.1 Salvin Dental Specialties,Inc Company Information
11.17.2 Salvin Dental Specialties,Inc Overview
11.17.3 Salvin Dental Specialties,Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 Salvin Dental Specialties,Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Products and Services
11.17.5 Salvin Dental Specialties,Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Value Chain Analysis
12.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Production Mode & Process
12.4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales and Marketing
12.4.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Channels
12.4.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Distributors
12.5 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Customers
13 Market Dynamics
13.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Trends
13.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Drivers
13.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Challenges
13.4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Absorbable Membrane
Table 3. Major Manufacturers of Non-resorbable Membrane
Table 4. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Region (2018-2024)
Table 8. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Region (2024-2034)
Table 10. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2018-2024) & (K Units)
Table 12. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region (2018-2024)
Table 13. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2024-2034) & (K Units)
Table 14. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region (2024-2034)
Table 15. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Manufacturers (2018-2024)
Table 19. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Manufacturers 2018-2024 (US$/Unit)
Table 20. Global Key Players of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Industry Ranking, 2021 VS 2022
Table 21. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane as of 2022)
Table 23. Global Key Manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Product Offered and Application
Table 25. Global Key Manufacturers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Share by Type (2018-2024)
Table 30. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Share by Type (2024-2034)
Table 31. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Type (2018-2024)
Table 34. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Type (2024-2034)
Table 35. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Share by Application (2018-2024)
Table 40. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Share by Application (2024-2034)
Table 41. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Application (2018-2024)
Table 44. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Application (2024-2034)
Table 45. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Geistlich Pharma Company Information
Table 118. Geistlich Pharma Description and Overview
Table 119. Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 120. Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 121. Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 122. Geistlich Pharma Recent Developments
Table 123. Keystone Dental Company Information
Table 124. Keystone Dental Description and Overview
Table 125. Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 126. Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 127. Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 128. Keystone Dental Recent Developments
Table 129. Yantai Zhenghai Bio-tech Company Information
Table 130. Yantai Zhenghai Bio-tech Description and Overview
Table 131. Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 132. Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 133. Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 134. Yantai Zhenghai Bio-tech Recent Developments
Table 135. Bio-tech Company Information
Table 136. Bio-tech Description and Overview
Table 137. Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 138. Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 139. Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 140. Bio-tech Recent Developments
Table 141. Genoss Company Information
Table 142. Genoss Description and Overview
Table 143. Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 144. Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 145. Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 146. Genoss Recent Developments
Table 147. MegaGen Impant Company Information
Table 148. MegaGen Impant Description and Overview
Table 149. MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 150. MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 151. MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 152. MegaGen Impant Recent Developments
Table 153. Sunstar Company Information
Table 154. Sunstar Description and Overview
Table 155. Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 156. Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 157. Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 158. Sunstar Recent Developments
Table 159. OraPharma Company Information
Table 160. OraPharma Description and Overview
Table 161. OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 162. OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 163. OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 164. OraPharma Recent Developments
Table 165. Biomedical Tissues Company Information
Table 166. Biomedical Tissues Description and Overview
Table 167. Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 168. Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 169. Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 170. Biomedical Tissues Recent Developments
Table 171. Botiss Company Information
Table 172. Botiss Description and Overview
Table 173. Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 174. Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 175. Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane SWOT Analysis
Table 176. Botiss Recent Developments
Table 177. Dentsply Sirona Company Information
Table 178. Dentsply Sirona Description and Overview
Table 179. Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 180. Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 181. Dentsply Sirona Recent Developments
Table 182. Zimmer Biomet Company Information
Table 183. Zimmer Biomet Description and Overview
Table 184. Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 185. Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 186. Zimmer Biomet Recent Developments
Table 187. Lynch Biologics Company Information
Table 188. Lynch Biologics Description and Overview
Table 189. Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 190. Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 191. Lynch Biologics Recent Developments
Table 192. Neoss Limited Company Information
Table 193. Neoss Limited Description and Overview
Table 194. Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 195. Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 196. Neoss Limited Recent Developments
Table 197. Biomatlante Company Information
Table 198. Biomatlante Description and Overview
Table 199. Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 200. Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 201. Biomatlante Recent Developments
Table 202. Nobel Biocare Services/Danaher Corporation Company Information
Table 203. Nobel Biocare Services/Danaher Corporation Description and Overview
Table 204. Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 205. Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 206. Nobel Biocare Services/Danaher Corporation Recent Developments
Table 207. Salvin Dental Specialties,Inc Company Information
Table 208. Salvin Dental Specialties,Inc Description and Overview
Table 209. Salvin Dental Specialties,Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 210. Salvin Dental Specialties,Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product and Services
Table 211. Salvin Dental Specialties,Inc Recent Developments
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Distributors List
Table 215. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Customers List
Table 216. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Trends
Table 217. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Drivers
Table 218. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Challenges
Table 219. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Restraints
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Picture
Figure 2. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Share by Type in 2022 & 2034
Figure 4. Absorbable Membrane Product Picture
Figure 5. Non-resorbable Membrane Product Picture
Figure 6. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Dental
Figure 11. Other
Figure 12. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Report Years Considered
Figure 13. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue 2018-2034 (US$ Million)
Figure 15. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity 2018-2034 (K Units)
Figure 17. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Quantity Market Share by Region (2024-2034)
Figure 19. Nort